Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

PHASE2TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
Interventions
DRUG

FOLFOX6

5-FU, folinic acid, oxaliplatin

BIOLOGICAL

Bevacizumab

Targeted therapy

BIOLOGICAL

Panitumumab

Targeted therapy

PROCEDURE

Surgery

Trial Locations (25)

75015

Hopital Europeen Georges Pompidou, Paris

A-1090

Allgemeines Krankenhaus der Stadt Wien, Vienna

Unknown

Hopital Universitaire Brugmann, Brussels

Universitair Ziekenhuis Gent, Ghent

AZ Groeninge Kortrijk - Campus Kennedylaan, Kortrijk

AZ Turnhout - Campus Sint Elisabeth, Turnhout

Centre Hospitalier Peltzer-La Tourelle, Verviers

Institut Sainte Catherine, Avignon

Institut Bergonie, Bordeaux

Assistance Publique - Hôpitaux de Paris - Hopital De Bicetre AP-HP, Le Kremlin-Bicêtre

Centre Hospitalier Saint Joseph Saint Luc, Lyon

Centre Leon Berard, Lyon

Hopital Prive Jean Mermoz, Lyon

Centre Antoine Lacassagne, Nice

Groupe Hospitalier Diaconesses Croix Saint-Simon - Site Reuilly, Paris

CHU de Lyon - Centre Hospitalier Lyon Sud, Pierre-Benite (lyon)

CHU de Reims - Hôpital Robert Debré, Reims

Hopital Charles Nicolle, Rouen

Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire

CHU Saint-Etienne - CHU de Saint-Etienne - Hopital Nord, Saint-Priest-en-Jarez

CHU d'Amiens - CHU Amiens - Hopital Sud, Salouël

The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam

Hospital General Vall D'Hebron, Barcelona

Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie, Geneva

F-92104

CHU Ambroise Pare, Boulogne-Billancourt

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK